Connection

Alessandro Rambaldi to Antineoplastic Combined Chemotherapy Protocols

Back to Details
This is a "connection" page, showing publications Alessandro Rambaldi has written about Antineoplastic Combined Chemotherapy Protocols.
Alessandro Rambaldi
Connection Strength
0.893
Antineoplastic Combined Chemotherapy Protocols
  1. Minimal Residual Disease Assessment and Risk-based Therapy in Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk. 2017 07; 17S:S2-S9.
    View in: PubMed
    Score: 0.324
  2. Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell Lymphomas. J Clin Oncol. 2016 11 20; 34(33):4015-4022.
    View in: PubMed
    Score: 0.310
  3. Infection control in patients treated for chronic lymphocytic leukemia with ibrutinib or idelalisib: recommendations from Italian society of hematology. Leuk Res. 2019 06; 81:88-94.
    View in: PubMed
    Score: 0.092
  4. Reply to H.J.A. Adams et al and C. Mesguich et al. J Clin Oncol. 2018 07 10; 36(20):2125-2126.
    View in: PubMed
    Score: 0.086
  5. TP53 in adult acute lymphoblastic leukemia. Leuk Lymphoma. 2018 04; 59(4):778-789.
    View in: PubMed
    Score: 0.081
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.